432P - QTWiST analysis to compare the benefit of maintenance Erlotinib versus pemetrexed patients with EGFR non mutated NSCLC
| Autor: | Turkar, S., Joshi, A., Noronha, V., Patil, V., Sharma, M., Vora, C., More, S., Goud, S., Prabhash, K. |
|---|---|
| Zdroj: | In Annals of Oncology November 2017 28 Supplement 10:x132-x132 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|